Literature DB >> 9576133

Difference between clinic and daytime blood pressure is not a measure of the white coat effect.

G Parati1, L Ulian, C Santucciu, S Omboni, G Mancia.   

Abstract

The purpose of the present study was to evaluate whether the difference between blood pressure measured in the clinic or physician's office and the average daytime blood pressure accurately reflects the blood pressure response of the patient to the physician ("white coat effect" or "white coat hypertension"). We studied 28 hypertensive outpatients (mean age, 41.8+/-11.2 years; age range, 21 to 64 years) of 35 consecutive patients attending our hypertension clinic, in whom (1) continuous noninvasive finger blood pressure was recorded before and during the visit, (2) blood pressure was measured according to the Riva-Rocci-Korotkoff method (mercury sphygmomanometer) with the patient in the supine position, and (3) daytime ambulatory blood pressure was monitored with a SpaceLabs 90207 device. The peak blood pressure increase recorded directly during the visit was compared with the difference between clinic and daytime average ambulatory blood pressures. Compared with previsit values, peak increases in finger systolic and diastolic blood pressures during the visit to the clinic were 38.2+/-3.1 and 20.7+/-1.6 mm Hg, respectively (mean+/-SEM, P<.01 for both). Daytime average systolic and diastolic blood pressures were 135.5+/-2.5 and 89.2+/-1.9 mm Hg, with both lower than the corresponding clinic blood pressure values (146.6+/-3.6 and 94.9+/-2.2 mm Hg, P<.01). These differences, however, were <30% of the peak finger blood pressure increases during the physician's visit, to which these increases showed no relation. Although the visit to the physician's office was associated with tachycardia (9.0+/-1.6 bpm, P<.01), there was no difference between clinic and daytime average heart rates. These data indicate that the clinic-daytime average blood pressure difference does not reflect the alerting reaction and the pressure response elicited by the physician's visit and thus is not a reliable measure of the white coat effect.

Entities:  

Mesh:

Year:  1998        PMID: 9576133     DOI: 10.1161/01.hyp.31.5.1185

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Comparison of different measures of blood pressure. Use sphygmomanometers more, not less.

Authors:  William T Hamilton; Deborah Sharp
Journal:  BMJ       Date:  2002-12-07

2.  Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.

Authors:  Alejandro Velasco; Colby Ayers; Sandeep R Das; James A de Lemos; Amit Khera; Ronald G Victor; Norman M Kaplan; Wanpen Vongpatanasin
Journal:  J Hypertens       Date:  2016-02       Impact factor: 4.844

Review 3.  Diagnosis and management of patients with white-coat and masked hypertension.

Authors:  Giuseppe Mancia; Michele Bombelli; Gino Seravalle; Guido Grassi
Journal:  Nat Rev Cardiol       Date:  2011-08-09       Impact factor: 32.419

4.  Predictors of the community pharmacy white-coat effect in treated hypertensive patients. The MEPAFAR study.

Authors:  Daniel Sabater-Hernández; Pablo Sánchez-Villegas; José P García-Corpas; Pedro Amariles; José Sendra-Lillo; María J Faus
Journal:  Int J Clin Pharm       Date:  2011-04-27

5.  Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality.

Authors:  T Alafia Samuels; Shari Bolen; H C Yeh; Marcela Abuid; Spyridon S Marinopoulos; Jonathan P Weiner; Maura McGuire; Frederick L Brancati
Journal:  J Gen Intern Med       Date:  2008-09-12       Impact factor: 5.128

6.  Should doctors still measure blood pressure?

Authors:  Thomas G Pickering
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-06       Impact factor: 3.738

7.  Epidemiological Characteristics of Hypertension in the Elderly in Beijing, China.

Authors:  Lina Ma; Xiaoling Zhao; Zhe Tang; Yun Li; Fei Sun; Lijun Diao; Gaizhen Ge; Ming Feng; Jieyu Wang
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 8.  Prognostic value of blood pressure variability and average blood pressure levels in patients with hypertension and diabetes.

Authors:  Gianfranco Parati; Juan Eugenio Ochoa; Paolo Salvi; Carolina Lombardi; Grzegorz Bilo
Journal:  Diabetes Care       Date:  2013-08       Impact factor: 19.112

Review 9.  Ambulatory blood pressure monitoring over 24 h: A Latin American Society of Hypertension position paper-accessibility, clinical use and cost effectiveness of ABPM in Latin America in year 2020.

Authors:  Ramiro A Sánchez; José Boggia; Ernesto Peñaherrera; Weimar Sebba Barroso; Eduardo Barbosa; Raúl Villar; Leonardo Cobos; Rafael Hernández Hernández; Jesús Lopez; José Andrés Octavio; José Z Parra Carrillo; Agustín J Ramírez; Gianfranco Parati
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-02-12       Impact factor: 3.738

10.  Subclinical Organ Damage in White-Coat Hypertension: The Possible Role of Cystatin C.

Authors:  Emmanuel Androulakis; Nikolaos Papageorgiou; Eirini Lioudaki; Evaggelos Chatzistamatiou; Effimia Zacharia; Ioannis Kallikazaros; Dimitris Tousoulis
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-07-21       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.